# 1st Gen Model DaVita healthCare Partners Inc. Miscellaneous health & allied services, not elsewhere classified

Subscribe >> Deal exit on
Aug. 22, 2017
Deal entry on
Aug. 22, 2017
1.26%Expected margin
77.33% successful of 75 deals
$56.47 Last close price
at 21-aug-2017

DVA

Model's trade recommendations 2.93% Return for period

10.40% Annual return

$10.75B Market Cap

β 0.89  

DVA

Model (following trade recommendations)

DVA

Underlying stock

S&P 500

Index
Return for period 2.93%
-13.61%
1.78%
52wk return 11.09%
-13.35%
16.82%
52wk Range
55.16—70.09
2000.54—2399.63
Sortino ratio 1.50
Sharpe ratio 1.01
Norm. RMSE 0.84%
Downside risk 6.72%
Volatility 9.98%
  • HOLD Analysts consensus recommendation

DaVita Inc. is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a provider of kidney care, delivering dialysis services for chronic kidney failure and end stage renal disease primarily in the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks primarily in California, Nevada, New Mexico, Florida, Colorado and Washington. DaVita Inc., formerly known as DaVita HealthCare Partners Inc., is headquartered in Denver, Colorado.

Industry sector: Medical

Sector classification: Miscellaneous health & allied services, not elsewhere classified

Deep Learning based analysis and prediction model for DaVita healthCare Partners Inc. (DVA) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 22, 2015.

Market data for DVA model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 187M
P/E 15.45
Shares Outstanding 191M
% Held by Insiders 2.00%
% Held by Institutions 83.53%
EPS (last reported FY) $3.85
EPS (last reported Q) $0.92
EPS, estimated (last reported Q) $0.90
Total revenues $15 B
Net income $1 B